In summary, the reporter assays and ChIP assay impliacte that an estrogen-dependent ERα-ΔNp63-integrin β4 signaling pathway promoted the cell viability and motility of ERα-positive breast cancer cells. This evidence concerns the gene ESR1 and breast cancer.